Blood & Cancer
Real-world checkpoint inhibitor results not as good as trial results
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:09
- Mas informaciones
Informações:
Sinopsis
Hematology Oncology News: IMRT new standard of care for high-risk cervical cancer: https://bit.ly/3k7ji3y Real-world results with checkpoint inhibitors found inferior to trial results: https://bit.ly/35cIt0v Are HMAS appropriate for posttransplant maintenance in acute leukemias?: https://bit.ly/3lfqsE7 You can email the show at podcasts@mdedge.com.
